The Lindner Center for Research and Education at the Christ Hospital

Cincinnati, Ohio 45219

3 studies enrolling now · 20 studies all time

What they study most

Aortic Valve Stenosis, Atrial Fibrillation, Cardiovascular Disease, Chronic Heart Failure With Reduced Ejection Fraction, Chronic Limb Threatening Ischemia, Fecal Incontinence, Heart Failure, Heart Failure With Preserved Ejection Fraction, High Blood Pressure, Hyperlipidemia, Hypertension, Ischaemic Ulcer of Lower Leg Due to Atherosclerotic Disease

Studies at this site

• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study — Recruiting now
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation — Recruiting now
• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — Running, not enrolling
• Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF — Completed
• Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer — Stopped early
• Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer — Stopped early
• A Study to Assess the Safety, Tolerability and Efficacy of IONIS-AGT-LRx in Participants With Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial — Stopped early
• Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer — Withdrawn before enrolling
• Ruboxistaurin in New York Heart Failure Classification III-IV Patients — Withdrawn before enrolling
• Long-Term, Open Label Extension Study of Pemziviptadil (PB1046) in PAH Subjects Following Completion of Study PB1046-PT-CL-0004 — Stopped early
• Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers — Status unconfirmed
• Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
• A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension — Stopped early
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery — Completed
• Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence — Stopped early